chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Felt like she had covid again; Body aches; Sore arm; Chills; Fever; Headaches; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Felt like she had covid again), PAIN (Body aches), PAIN IN EXTREMITY (Sore arm), CHILLS (Chills) and PYREXIA (Fever) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038a21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in 2020. Concomitant products included ROSUVASTATIN and VITAMINS NOS for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced COVID-19 (Felt like she had covid again), PAIN (Body aches), PAIN IN EXTREMITY (Sore arm), CHILLS (Chills), PYREXIA (Fever), HEADACHE (Headaches) and FATIGUE (Fatigue). At the time of the report, COVID-19 (Felt like she had covid again), PAIN (Body aches), PAIN IN EXTREMITY (Sore arm), CHILLS (Chills), PYREXIA (Fever), HEADACHE (Headaches) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided. Concomitant medications included  Seizure meds and Blood pressure meds.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Lightheadedness) and VACCINATION SITE PAIN (Soreness at the site of injection) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination. No Medical History information was reported. On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the site of injection). On 11-Mar-2021, the patient experienced DIZZINESS (Lightheadedness). At the time of the report, DIZZINESS (Lightheadedness) and VACCINATION SITE PAIN (Soreness at the site of injection) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (COVID 19 Vaccine Moderna) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided. Treatment medication was not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pyrexia
Clinical narrative: chills/slightly elevated; fatigue/slightly elevated; Slight fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills/slightly elevated), FATIGUE (fatigue/slightly elevated) and PYREXIA (Slight fever) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048A21H and 031L200) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis, Macular degeneration, Pulmonary fibrosis, Drug allergy (Percocet), Chronic bronchitis and COPD. Concomitant products included VITAMINS NOS for Macular degeneration, MOMETASONE FUROATE (ASMANEX) for Pulmonary fibrosis, RITUXIMAB (RITUXAN) for Rheumatoid arthritis, BUDESONIDE, FORMOTEROL FUMARATE (SYMBICORT), ATORVASTATIN, ASCORBIC ACID, BETACAROTENE, CUPRIC OXIDE, TOCOPHERYL ACETATE, ZINC OXIDE (PRESERVISION), LEVOTHYROXINE and VITAMIN D3 for an unknown indication.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced CHILLS (chills/slightly elevated), FATIGUE (fatigue/slightly elevated) and PYREXIA (Slight fever). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) for Adverse event, at an unspecified dose and frequency. On 12-Mar-2021, CHILLS (chills/slightly elevated), FATIGUE (fatigue/slightly elevated) and PYREXIA (Slight fever) had resolved.            The patient got rituximab infusions every 6 months for rheumatoid arthritis.  The patient had a compromised immune system due to the rituximab.    The patient normally had fatigue with rheumatoid arthritis, but with the vaccine patient had a double dose of fatigue.  Patient reported that she is taking Rituximab for Rheumatoid Arthritis(RA). It is also reported that there are flare ups of RA, but the patient is not sure whether because of the vaccine. Patient states that possibly the vaccine caused immune system to respond therefore a flare up in RA.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Medical history updated. On 25-Jul-2021: No new information reported. On 07-Aug-2021: Non-Significant Follow up received and reporter information updated
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vaccination site erythema, Vaccination site induration, Vaccination site warmth
Clinical narrative: warm; bruise; knot in the arm; red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm), VACCINATION SITE BRUISING (bruise), VACCINATION SITE INDURATION (knot in the arm) and VACCINATION SITE ERYTHEMA (red) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION SITE WARMTH (warm), VACCINATION SITE BRUISING (bruise), VACCINATION SITE INDURATION (knot in the arm) and VACCINATION SITE ERYTHEMA (red). At the time of the report, VACCINATION SITE WARMTH (warm), VACCINATION SITE BRUISING (bruise), VACCINATION SITE INDURATION (knot in the arm) and VACCINATION SITE ERYTHEMA (red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided.   Reporter did not allow further contact
Age: 83.0
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Knee pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Knee pain) in an 83-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced ARTHRALGIA (Knee pain). At the time of the report, ARTHRALGIA (Knee pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medicine use was not provided by the reporter.  Zilretta injection was scheduled, the patient will discuss when to receive injection with HCP.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Tinnitus
Clinical narrative: Whooshing sound in ear; Body aches; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Whooshing sound in ear), MYALGIA (Body aches) and PYREXIA (Low grade fever) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A211A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced TINNITUS (Whooshing sound in ear), MYALGIA (Body aches) and PYREXIA (Low grade fever). At the time of the report, TINNITUS (Whooshing sound in ear), MYALGIA (Body aches) and PYREXIA (Low grade fever) outcome was unknown.            No relevant concomitant medications were provided.  The patient reported that whooshing sound in her ear was being worse when lying down. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Fatigue
Clinical narrative: Arm pain; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (Arm pain) and FATIGUE (Fatigue) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy. Concomitant products included LEVONORGESTREL (KYLEENA) for Birth control, LORATADINE (CLARITIN [LORATADINE]) for Seasonal allergy, VITAMIN C [ASCORBIC ACID] and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced AXILLARY PAIN (Arm pain) and FATIGUE (Fatigue). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of 1 UNK and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, AXILLARY PAIN (Arm pain) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment includes fluids.   This case was linked to MOD-2021-044522 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Significant follow up was received on 07-june-2021 patient medical history, concomitant medication, demographics, second  dose details was updated
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site erythema, Vaccination site swelling
Clinical narrative: It has increased in size to become a fairly sizeable rash over the past week; Small nickel-sized red patch at injection site; Minor swelling at injection site; This spontaneous case was reported by a consumer and describes the occurrence of RASH (It has increased in size to become a fairly sizeable rash over the past week), VACCINATION SITE ERYTHEMA (Small nickel-sized red patch at injection site) and VACCINATION SITE SWELLING (Minor swelling at injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  .  Concomitant products included LISINOPRIL for an unknown indication.    On 06-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced RASH (It has increased in size to become a fairly sizeable rash over the past week), VACCINATION SITE ERYTHEMA (Small nickel-sized red patch at injection site) and VACCINATION SITE SWELLING (Minor swelling at injection site). At the time of the report, RASH (It has increased in size to become a fairly sizeable rash over the past week), VACCINATION SITE ERYTHEMA (Small nickel-sized red patch at injection site) and VACCINATION SITE SWELLING (Minor swelling at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Swelling at the site has decreased while the size has spread.  No treatment information was provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Induration, Joint swelling, Muscle spasms, Neck pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), BACK PAIN, NECK PAIN, PAIN IN EXTREMITY, and VACCINATION SITE REACTION (right arm, but all my symptoms are in left side of body) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  .  Concomitant products included MONTELUKAST for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 06-Mar-2021, the patient experienced BACK PAIN, NECK PAIN, and PAIN IN EXTREMITY. On an unknown date, the patient experienced VACCINATION SITE REACTION, JOINT SWELLING, MUSCLE SPASMS, PAIN, PAIN IN EXTREMITY, SWELLING, and INDURATION. The patient was treated with TYLENOL at an unspecified dose and frequency and ALEVE at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm), BACK PAIN, NECK PAIN, PAIN IN EXTREMITY, VACCINATION SITE REACTION, JOINT SWELLING, MUSCLE SPASMS, PAIN, PAIN IN EXTREMITY, SWELLING, and INDURATION outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient stated that that it is happening for so long and went to her doctor regarding these concerns. Other concomitant medications included Vitamins.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Swelling, Vaccination site reaction
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), BACK PAIN, NECK PAIN, PAIN IN EXTREMITY, and VACCINATION SITE REACTION (right arm, but all my symptoms are in left side of body) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  .  Concomitant products included MONTELUKAST for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 06-Mar-2021, the patient experienced BACK PAIN, NECK PAIN, and PAIN IN EXTREMITY. On an unknown date, the patient experienced VACCINATION SITE REACTION, JOINT SWELLING, MUSCLE SPASMS, PAIN, PAIN IN EXTREMITY, SWELLING, and INDURATION. The patient was treated with TYLENOL at an unspecified dose and frequency and ALEVE at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm), BACK PAIN, NECK PAIN, PAIN IN EXTREMITY, VACCINATION SITE REACTION, JOINT SWELLING, MUSCLE SPASMS, PAIN, PAIN IN EXTREMITY, SWELLING, and INDURATION outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient stated that that it is happening for so long and went to her doctor regarding these concerns. Other concomitant medications included Vitamins.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Insomnia
Clinical narrative: Not feeling good; Not able to sleep; Tired; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Not feeling good), INSOMNIA (Not able to sleep) and FATIGUE (Tired) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concomitant products included ATORVASTATIN and LEVOTHYROXINE for an unknown indication.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced FEELING ABNORMAL (Not feeling good), INSOMNIA (Not able to sleep) and FATIGUE (Tired). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (Not feeling good), INSOMNIA (Not able to sleep) and FATIGUE (Tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Nasal congestion, Nasal pruritus, Pain in extremity, Paraesthesia
Clinical narrative: Pain in her arm; Tingling; Weird feeling going through body; stuffy nose, itchy nose; stuffy nose, itchy nose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in her arm), PARAESTHESIA (Tingling), FEELING ABNORMAL (Weird feeling going through body), NASAL CONGESTION (Stuffy nose) and NASAL PRURITUS (Itchy nose) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     Concurrent medical conditions included Multiple sclerosis and Trigeminal neuralgia. Concomitant products included PREGABALIN for Trigeminal neuralgia, ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in her arm), PARAESTHESIA (Tingling), FEELING ABNORMAL (Weird feeling going through body), NASAL CONGESTION (Stuffy nose) and NASAL PRURITUS (Itchy nose). At the time of the report, PAIN IN EXTREMITY (Pain in her arm), PARAESTHESIA (Tingling), FEELING ABNORMAL (Weird feeling going through body), NASAL CONGESTION (Stuffy nose) and NASAL PRURITUS (Itchy nose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product also included Octravis for Multiple sclerosis.  No treatment information was provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Myalgia, Peripheral coldness, Pyrexia
Clinical narrative: Hands would be really really cold; Chills; Fever/fever 102 F; COVID hands; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL COLDNESS (Hands would be really really cold), CHILLS (Chills), PYREXIA (Fever/fever 102 F) and MYALGIA (COVID hands) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 030M20A) for COVID-19 vaccination.     Concomitant products included CALCIUM (VIACTIV [CALCIUM]) for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced PERIPHERAL COLDNESS (Hands would be really really cold), CHILLS (Chills), PYREXIA (Fever/fever 102 F) and MYALGIA (COVID hands). The patient was treated with NAPROXEN SODIUM (ALEVE) ongoing from 12-Mar-2021 for Fever, at a dose of UNK, qd, noon. On 15-Mar-2021, PERIPHERAL COLDNESS (Hands would be really really cold), CHILLS (Chills) and PYREXIA (Fever/fever 102 F) had resolved. At the time of the report, MYALGIA (COVID hands) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, Body temperature: 102 f (High) Fever.         concomitant medication Viactiv used for bone health.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow up received on 14-JUL-2021.Concomitant medications were added and event outcome was updated.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Headache, Influenza like illness, Pain
Clinical narrative: flu like symptoms; light headache; soreness; not a bad cough; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), HEADACHE (light headache), PAIN (soreness) and COUGH (not a bad cough) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 026A21A) for an unknown indication.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), HEADACHE (light headache), PAIN (soreness) and COUGH (not a bad cough). At the time of the report, HEADACHE (light headache), PAIN (soreness) and COUGH (not a bad cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment included cough drops
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: Itchy rash around the site of the injection; Rash around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy rash around the site of the injection) and VACCINATION SITE RASH (Rash around the injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Itchy rash around the site of the injection) and VACCINATION SITE RASH (Rash around the injection site). At the time of the report, VACCINATION SITE PRURITUS (Itchy rash around the site of the injection) and VACCINATION SITE RASH (Rash around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment provided include anti-itch cream.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Severe headache on one side of the head/ Had the same headache on the other side of the head/ pretty bad pain in her head, on both sides; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Severe headache on one side of the head/ Had the same headache on the other side of the head/ pretty bad pain in her head, on both sides) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Cholesterol high. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced HEADACHE (Severe headache on one side of the head/ Had the same headache on the other side of the head/ pretty bad pain in her head, on both sides). The patient was treated with PARACETAMOL (TYLENOL) on 14-Mar-2021 for Headache, at an unspecified dose and frequency and HYDROCORTISONE on 15-Mar-2021 for Headache, at a dose of Half pill. At the time of the report, HEADACHE (Severe headache on one side of the head/ Had the same headache on the other side of the head/ pretty bad pain in her head, on both sides) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Other concomitant medications included blood pressure medication and cholesterol medication.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site swelling
Clinical narrative: Thumb Pain; Redness - Near Injection Site; Swelling - Near Injection Site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Thumb Pain), VACCINATION SITE ERYTHEMA (Redness - Near Injection Site) and VACCINATION SITE SWELLING (Swelling - Near Injection Site) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (Thumb Pain), VACCINATION SITE ERYTHEMA (Redness - Near Injection Site) and VACCINATION SITE SWELLING (Swelling - Near Injection Site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Thumb Pain), VACCINATION SITE ERYTHEMA (Redness - Near Injection Site) and VACCINATION SITE SWELLING (Swelling - Near Injection Site) outcome was unknown.            No relevant concomitant medications were reported.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore, the action taken with the drug in response to the events was not applicable.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Fatigue, Lethargy
Clinical narrative: had "loose stools" and  bad diarrhea/worst diarrhea episode/very serious diarrhea; needed to lie down; exhausted; lethargic; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (lethargic), DIARRHOEA (had "loose stools" and  bad diarrhea/worst diarrhea episode/very serious diarrhea), ASTHENIA (needed to lie down) and FATIGUE (exhausted) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036A21A and 013M20A) for COVID-19 vaccination.     The patient's past medical history included Pityriasis rubra pilaris (Pityriasis Rubra Pilaris (PRP) diagnosis 5 or 6 years ago.), Flu (Flu infection that caused diarrhea.) from February 2020 to March 2020, Salivary gland cancer (Cancer of parotid salivary gland that involved surgery, chemotherapy and radiation.) in August 2019, Dialysis (Patient was hospitalized and was placed on dialysis.) in September 2020 and Heart attack in September 2020. Concomitant products included ALLOPURINOL, AMIODARONE, ATORVASTATIN, MACROGOL 3350 (CLEARLAX [MACROGOL 3350]), APIXABAN (ELIQUIS), FLUOROURACIL, FOLIC ACID, LEVOTHYROXINE, METOPROLOL SUCCINATE, MIRTAZAPINE, OMEPRAZOLE, LIOTHYRONINE SODIUM (THYRONINE), TIMOLOL, AMLODIPINE BESILATE, ATENOLOL (BETACAL [AMLODIPINE BESILATE;ATENOLOL]), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), USTEKINUMAB (STELARA) and LISINOPRIL for an unknown indication.   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced LETHARGY (lethargic), ASTHENIA (needed to lie down) and FATIGUE (exhausted). On 10-Mar-2021, the patient experienced DIARRHOEA (had "loose stools" and  bad diarrhea/worst diarrhea episode/very serious diarrhea). On 15-Mar-2021, DIARRHOEA (had "loose stools" and  bad diarrhea/worst diarrhea episode/very serious diarrhea) had resolved. At the time of the report, LETHARGY (lethargic), ASTHENIA (needed to lie down) and FATIGUE (exhausted) outcome was unknown.            No treatment was reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Slight fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Slight fever) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Slight fever). At the time of the report, PYREXIA (Slight fever) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. No concomitant medications were reported.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Headache, Pain in extremity, Vomiting
Clinical narrative: diarrhea and vomiting; diarrhea and vomiting; headache; arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt), DIARRHOEA (diarrhea and vomiting), VOMITING (diarrhea and vomiting) and HEADACHE (headache) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0131A21A and 031L20A) for COVID-19 vaccination.     The patient's past medical history included Eczema and Anaphylactic reaction. Concurrent medical conditions included RA and Allergic reaction NOS. Concomitant products included ADALIMUMAB (HUMIRA) and EPINEPHRINE (EPIPEN) for an unknown indication.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm hurt) and HEADACHE (headache). On 28-Feb-2021, the patient experienced DIARRHOEA (diarrhea and vomiting) and VOMITING (diarrhea and vomiting). On 01-Mar-2021, DIARRHOEA (diarrhea and vomiting), VOMITING (diarrhea and vomiting) and HEADACHE (headache) had resolved. At the time of the report, PAIN IN EXTREMITY (arm hurt) outcome was unknown.            No treatment was reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Nervousness, Vaccination site pain
Clinical narrative: pulsating feeling in her left arm, in her muscle; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (pulsating feeling in her left arm, in her muscle) and VACCINATION SITE PAIN (sore arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 002A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore arm). On 31-Jan-2021, the patient experienced NERVOUSNESS (pulsating feeling in her left arm, in her muscle). On 31-Jan-2021, VACCINATION SITE PAIN (sore arm) had resolved. At the time of the report, NERVOUSNESS (pulsating feeling in her left arm, in her muscle) had not resolved.            No concomitant product was reported.   No treatment information was reported.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Bad rash on the same arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Bad rash on the same arm of injection) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced VACCINATION SITE RASH (Bad rash on the same arm of injection). The patient was treated with OXYCODONE for Rash, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE RASH (Bad rash on the same arm of injection) outcome was unknown. Not Provided          No concomitant medication was reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Muscular weakness
Clinical narrative: weakness in arm and legs occurred 12 hours after the vaccine and lasted for approximately 10; weakness effected the left leg the most; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (weakness in arm and legs occurred 12 hours after the vaccine and lasted for approximately 10) and ASTHENIA (weakness effected the left leg the most) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced MUSCULAR WEAKNESS (weakness in arm and legs occurred 12 hours after the vaccine and lasted for approximately 10) and ASTHENIA (weakness effected the left leg the most). On 11-Mar-2021, MUSCULAR WEAKNESS (weakness in arm and legs occurred 12 hours after the vaccine and lasted for approximately 10) and ASTHENIA (weakness effected the left leg the most) had resolved. Related      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by reporter. Treatment medication not reported.   This case was linked to MOD21-053599, MOD-2021-044549 (Patient Link).
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Pyrexia, Vaccination site rash
Clinical narrative: Migraine headache; Fever; Rash at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine headache), PYREXIA (Fever) and VACCINATION SITE RASH (Rash at the site of injection) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Migraine headache), PYREXIA (Fever) and VACCINATION SITE RASH (Rash at the site of injection). At the time of the report, MIGRAINE (Migraine headache), PYREXIA (Fever) and VACCINATION SITE RASH (Rash at the site of injection) outcome was unknown.            The patient have a 10-month baby and the baby stopped breast feeding at the age of 4 months. No treatment was reported. No concomitant medication was reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling of body temperature change, Injection site rash, Pain, Pyrexia
Clinical narrative: rash is gone now and a little pink; tender, swollen, and itchy; red rash around the site of injection; tender, swollen, and itchy; tender, swollen, and itchy; felt "freezing cold" and "warm and cold."; chills, a slight temperature, and her body hurt all over.; chills, a slight temperature, and her body hurt all over; chills, a slight temperature, and her body hurt all over.; This spontaneous case was reported by a consumer and describes the occurrence of FEELING OF BODY TEMPERATURE CHANGE (felt "freezing cold" and "warm and cold."), SKIN DISCOLOURATION (rash is gone now and a little pink), PAIN (chills, a slight temperature, and her body hurt all over.), VACCINATION SITE PRURITUS (tender, swollen, and itchy) and PYREXIA (chills, a slight temperature, and her body hurt all over.) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced FEELING OF BODY TEMPERATURE CHANGE (felt "freezing cold" and "warm and cold."), PAIN (chills, a slight temperature, and her body hurt all over.), PYREXIA (chills, a slight temperature, and her body hurt all over.) and CHILLS (chills, a slight temperature, and her body hurt all over). On 07-Mar-2021, the patient experienced SKIN DISCOLOURATION (rash is gone now and a little pink), VACCINATION SITE PRURITUS (tender, swollen, and itchy), INJECTION SITE RASH (red rash around the site of injection), VACCINATION SITE PAIN (tender, swollen, and itchy) and VACCINATION SITE SWELLING (tender, swollen, and itchy). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 28-Feb-2021, FEELING OF BODY TEMPERATURE CHANGE (felt "freezing cold" and "warm and cold."), PAIN (chills, a slight temperature, and her body hurt all over.), PYREXIA (chills, a slight temperature, and her body hurt all over.) and CHILLS (chills, a slight temperature, and her body hurt all over) had resolved. On 12-Mar-2021, SKIN DISCOLOURATION (rash is gone now and a little pink), VACCINATION SITE PRURITUS (tender, swollen, and itchy), INJECTION SITE RASH (red rash around the site of injection), VACCINATION SITE PAIN (tender, swollen, and itchy) and VACCINATION SITE SWELLING (tender, swollen, and itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: followup received on 24-may-2021, No new information
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Skin discolouration, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: rash is gone now and a little pink; tender, swollen, and itchy; red rash around the site of injection; tender, swollen, and itchy; tender, swollen, and itchy; felt "freezing cold" and "warm and cold."; chills, a slight temperature, and her body hurt all over.; chills, a slight temperature, and her body hurt all over; chills, a slight temperature, and her body hurt all over.; This spontaneous case was reported by a consumer and describes the occurrence of FEELING OF BODY TEMPERATURE CHANGE (felt "freezing cold" and "warm and cold."), SKIN DISCOLOURATION (rash is gone now and a little pink), PAIN (chills, a slight temperature, and her body hurt all over.), VACCINATION SITE PRURITUS (tender, swollen, and itchy) and PYREXIA (chills, a slight temperature, and her body hurt all over.) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced FEELING OF BODY TEMPERATURE CHANGE (felt "freezing cold" and "warm and cold."), PAIN (chills, a slight temperature, and her body hurt all over.), PYREXIA (chills, a slight temperature, and her body hurt all over.) and CHILLS (chills, a slight temperature, and her body hurt all over). On 07-Mar-2021, the patient experienced SKIN DISCOLOURATION (rash is gone now and a little pink), VACCINATION SITE PRURITUS (tender, swollen, and itchy), INJECTION SITE RASH (red rash around the site of injection), VACCINATION SITE PAIN (tender, swollen, and itchy) and VACCINATION SITE SWELLING (tender, swollen, and itchy). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 28-Feb-2021, FEELING OF BODY TEMPERATURE CHANGE (felt "freezing cold" and "warm and cold."), PAIN (chills, a slight temperature, and her body hurt all over.), PYREXIA (chills, a slight temperature, and her body hurt all over.) and CHILLS (chills, a slight temperature, and her body hurt all over) had resolved. On 12-Mar-2021, SKIN DISCOLOURATION (rash is gone now and a little pink), VACCINATION SITE PRURITUS (tender, swollen, and itchy), INJECTION SITE RASH (red rash around the site of injection), VACCINATION SITE PAIN (tender, swollen, and itchy) and VACCINATION SITE SWELLING (tender, swollen, and itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: followup received on 24-may-2021, No new information
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Diarrhoea, Feeling abnormal, Headache, Pyrexia
Clinical narrative: red spot 4.5 inches below the vaccination sport and it was 2 and a half inches long and 2 inches wide; not feeling very good; diarrhea; headache; temperature; achy joint; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), FEELING ABNORMAL (not feeling very good), RASH MACULAR (red spot 4.5 inches below the vaccination sport and it was 2 and a half inches long and 2 inches wide), HEADACHE (headache) and PYREXIA (temperature) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Depression and Bone disorder (NOS). Concomitant products included RALOXIFENE for Bone disorder (NOS), OMEPRAZOLE for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced DIARRHOEA (diarrhea), HEADACHE (headache), PYREXIA (temperature) and ARTHRALGIA (achy joint). On 13-Mar-2021, the patient experienced FEELING ABNORMAL (not feeling very good). On 14-Mar-2021, the patient experienced RASH MACULAR (red spot 4.5 inches below the vaccination sport and it was 2 and a half inches long and 2 inches wide). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (diarrhea), FEELING ABNORMAL (not feeling very good), RASH MACULAR (red spot 4.5 inches below the vaccination sport and it was 2 and a half inches long and 2 inches wide), HEADACHE (headache), PYREXIA (temperature) and ARTHRALGIA (achy joint) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Additional concomitant medication included medication for depression
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Rash macular
Clinical narrative: red spot 4.5 inches below the vaccination sport and it was 2 and a half inches long and 2 inches wide; not feeling very good; diarrhea; headache; temperature; achy joint; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), FEELING ABNORMAL (not feeling very good), RASH MACULAR (red spot 4.5 inches below the vaccination sport and it was 2 and a half inches long and 2 inches wide), HEADACHE (headache) and PYREXIA (temperature) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Depression and Bone disorder (NOS). Concomitant products included RALOXIFENE for Bone disorder (NOS), OMEPRAZOLE for an unknown indication.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced DIARRHOEA (diarrhea), HEADACHE (headache), PYREXIA (temperature) and ARTHRALGIA (achy joint). On 13-Mar-2021, the patient experienced FEELING ABNORMAL (not feeling very good). On 14-Mar-2021, the patient experienced RASH MACULAR (red spot 4.5 inches below the vaccination sport and it was 2 and a half inches long and 2 inches wide). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (diarrhea), FEELING ABNORMAL (not feeling very good), RASH MACULAR (red spot 4.5 inches below the vaccination sport and it was 2 and a half inches long and 2 inches wide), HEADACHE (headache), PYREXIA (temperature) and ARTHRALGIA (achy joint) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Additional concomitant medication included medication for depression
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Sluggishness, Vaccination site discolouration, Vaccination site rash
Clinical narrative: sluggish; rash now looks like a Black and Blue Mark; Burgundy dark red rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of SLUGGISHNESS (sluggish), VACCINATION SITE DISCOLOURATION (rash now looks like a Black and Blue Mark) and VACCINATION SITE RASH (Burgundy dark red rash at injection site) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 004420A) for COVID-19 vaccination.     No medical history was reported by the reporter. .  Concomitant products included IBUPROFEN for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SLUGGISHNESS (sluggish), VACCINATION SITE DISCOLOURATION (rash now looks like a Black and Blue Mark) and VACCINATION SITE RASH (Burgundy dark red rash at injection site). At the time of the report, SLUGGISHNESS (sluggish), VACCINATION SITE DISCOLOURATION (rash now looks like a Black and Blue Mark) and VACCINATION SITE RASH (Burgundy dark red rash at injection site) outcome was unknown.            No treatment was reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Oropharyngeal pain
Clinical narrative: Throat pain; Headache; Fatigue; Pain in both wrists; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Throat pain), HEADACHE (Headache), FATIGUE (Fatigue) and ARTHRALGIA (Pain in both wrists) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Throat pain), HEADACHE (Headache), FATIGUE (Fatigue) and ARTHRALGIA (Pain in both wrists). At the time of the report, OROPHARYNGEAL PAIN (Throat pain), HEADACHE (Headache), FATIGUE (Fatigue) and ARTHRALGIA (Pain in both wrists) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was reported. No concomitant medication was reported